INS and type 2 diabetes mellitus: A number of pharmacologic therapies are currently available for T2DM patients based on (i) direct insulin administration, (ii) promoting insulin secretion, (iii) improving insulin sensitivity, and (iv) modulating metabolism and intestinal absorption of carbohydrates [5].